Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-06-30
Cash flows from operating activities
Net Income
-234,600
-263,300
-112,000
-27,200
-199,500
Depreciation & amortization
58,200
61,900
52,700
62,800
72,000
Deferred income taxes
-1,400
-600
-31,900
-34,700
-54,100
Stock based compensation
45,200
40,700
38,100
36,300
25,200
Change in working capital
30,700
27,000
-83,500
120,800
117,900
Accounts receivable
1,100
-12,500
-10,300
-8,800
64,000
Inventory
-1,900
-1,800
-2,900
1,600
1,600
Accounts Payable
-5,200
-3,700
-3,500
9,200
-10,700
Other working capital
-154,700
-184,200
-151,600
600
50,500
Other non-cash items
5,100
21,900
13,400
20,800
500
Net cash provided by operating activites
-96,300
-110,900
-106,300
18,600
60,700
Cash flows from investing activities
Investments in property, plant and equipment
-58,400
-73,300
-45,300
-18,000
-10,200
Acquisitions, net
-
0
-57,200
0
0
Purchases of investments
-
0
-103,200
-147,800
-60,800
Sales/Maturities of investments
48,600
105,200
128,200
61,100
69,000
Net cash used for investing activites
-9,800
31,900
-77,500
274,400
19,300
Cash flows from financing activities
Debt repayment
-100,300
-40,200
0
-226,400
-8,600
Common stock issued
-
117,600
0
0
-
Common stock repurchased
-
-
-
0
0
Other financing activites
-14,300
-10,500
-14,300
-16,000
-14,700
Net cash used privided by (used for) financing activities
149,000
152,900
-8,000
-150,600
-10,000
Net change in cash
42,500
74,500
-192,400
141,800
70,500
Cash at beginning of period
63,100
66,400
258,800
117,000
93,200
Cash at end of period
106,000
140,900
66,400
258,800
163,700
Free Cash Flow
Operating Cash Flow
-96,300
-110,900
-106,300
18,600
60,700
Capital Expenditure
-58,400
-73,300
-45,300
-18,000
-10,200
Free Cash Flow
-154,700
-184,200
-151,600
600
50,500
© 2024 Yahoo. All rights reserved.